You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TRK inhibitor

Showing 1 - 25 of 7,409
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Larotrectinib Sulfate
  • Houston, Texas
    M D Anderson Cancer Center
Apr 18, 2022

Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))

Completed
  • Solid Tumors Harboring NTRK Fusion
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Aurora, Colorado
  • +7 more
May 11, 2021

Solid Tumors Harboring NTRK Fusion Trial in Mannheim (Selitrectinib (BAY2731954))

Completed
  • Solid Tumors Harboring NTRK Fusion
  • Selitrectinib (BAY2731954)
  • Mannheim, Baden-Württemberg, Germany
    CRS Clinical-Research-Services Mannheim GmbH
Dec 28, 2020

Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Selitrectinib (BAY2731954))

Active, not recruiting
  • Solid Tumors Harboring NTRK Fusion
  • Selitrectinib (BAY2731954)
  • La Jolla, California
  • +28 more
Aug 18, 2022

Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))

Recruiting
  • Solid Tumors Harboring NTRK Fusion
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Los Angeles, California
  • +50 more
Jan 29, 2023

NTRK Family Gene Mutation Trial in Germany

Recruiting
  • NTRK Family Gene Mutation
    • Berlin, Germany
    • +22 more
    Jan 18, 2023

    Glioblastoma Multiforme Trial run by the NCI (AZD7451)

    Completed
    • Glioblastoma Multiforme
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    A Retro-/Prospective, Non-interventional, Cohort Study in Adult

    Active, not recruiting
    • Solid Tumor, Adult
    • +2 more
      • Amiens, France
      • +3 more
      Jul 22, 2022

      Drug-drug Interaction Trial in Tempe (PBI-200 Tablet, Ritonavir Oral Tablet, Cobicistat Oral Tablet)

      Completed
      • Drug-drug Interaction
      • PBI-200 Tablet
      • +2 more
      • Tempe, Arizona
        Celerion, Inc.
      Jan 11, 2023

      Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

      Recruiting
      • Locally Advanced Solid Tumors
      • +3 more
      • Oral repotrectinib (TPX-0005)
      • Los Angeles, California
      • +27 more
      Aug 9, 2022

      Solid Tumor Trial (TL118 Capsule)

      Not yet recruiting
      • Solid Tumor
      • TL118 Capsule
      • (no location specified)
      Aug 18, 2023

      CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)

      Active, not recruiting
      • Central Nervous System Neoplasm
      • +4 more
      • Larotrectinib Sulfate
      • Birmingham, Alabama
      • +81 more
      Jan 24, 2023

      NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

      Withdrawn
      • NSCLC Stage IV
      • combination regimen tremelimumab /durvalumab
      • platinum-based chemotherapy (SoC)
      • Gauting, Germany
        Asklepios Fachkliniken München-Gauting
      Sep 26, 2022

      Solid Tumors, Lymphomas Trial in Worldwide (TSR-011)

      Completed
      • Solid Tumors
      • Lymphomas
      • Goodyear, Arizona
      • +14 more
      Mar 25, 2019

      Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

      Recruiting
      • Breast Cancer
      • +15 more
      • Goodyear, Arizona
      • +146 more
      Aug 24, 2022

      Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))

      Recruiting
      • Solid Tumors Harboring NTRK Fusion
      • BAY2757556 (Larotrectinib, Vitrakvi)
      • Palo Alto, California
      • +158 more
      Aug 8, 2022

      NTRK Gene Fusion - Positive Advanced or Recurrent Solid

      Recruiting
      • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Multiple Locations, Japan
        Many locations
      Jan 20, 2023

      Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

      Not yet recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • TRK-950
      • +2 more
      • Chuo Ku, Japan
        Osaka International Cancer Institute
      Sep 14, 2023

      Solid Tumor Trial in Beijing (TQB3811)

      Recruiting
      • Solid Tumor
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Dec 2, 2021

      Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

      Recruiting
      • Bronchial Neoplasms
      • Cologne, Germany
      • +6 more
      Nov 2, 2022

      Phase 1, Solid Tumor, Adult Trial in Goyang, Seongnam, Seoul (NOV1601(CHC2014))

      Completed
      • Phase 1
      • Solid Tumor, Adult
      • Goyang, Gyeonggi-do, Korea, Republic of
      • +3 more
      Sep 8, 2021

      Called VICTORIA to Learn More About How Well Larotrectinib Works

      Active, not recruiting
      • Solid Tumors Harboring NTRK Fusion
      • Larotrectinib(Vitrakvi, BAY2757556)
      • Data on other treatments
      • Whippany, New Jersey
        Bayer
      Aug 22, 2022

      Cancer (With or Without Metastasis) Trial in Houston (TSN084)

      Recruiting
      • Cancer (With or Without Metastasis)
      • Houston, Texas
        MD Anderson Cancer Center
      Apr 22, 2022

      Topcon Tonometers CT-800 and TRK-2P and Haag-Streit Goldmann

      Completed
      • Intraocular Pressure
      • Topcon CT-800
      • Topcon TRK-2P
      • Andover, Massachusetts
        Andover Eye Associates
      Jun 6, 2022

      Solid Tumor Trial in Chuo Ku (TRK-950)

      Recruiting
      • Solid Tumor
      • TRK-950
      • Chuo Ku, Tokyo, Japan
        National Cancer Center Hospital
      Jul 6, 2022